In addition, pharmacological inhibition of the c-Jun activator, c-Jun N-terminal kinase (JNK), in the SU-DHL-1 ALK+ ALCL cell line resulted in cell cycle arrest in G2/M phase [87]. This evidence concerns the gene JUN and anaplastic large cell lymphoma.